Related Experiment Videos
Interference between human herpesvirus 7 and HIV-1 in mononuclear phagocytes
R W Crowley1, P Secchiero, D Zella
1Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, MD 20894, USA.
Journal of Immunology (Baltimore, Md. : 1950)
|March 1, 1996
Summary
Human herpesvirus 7 (HHV-7) significantly inhibits HIV-1 replication in macrophages. Pre-exposure to HHV-7 blocks HIV-1 entry into these critical immune cells, offering a potential new avenue for HIV-1 research.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Human herpesvirus 7 (HHV-7) utilizes CD4 as a cellular receptor, impacting human immunodeficiency virus type 1 (HIV-1) infection of CD4+ T cells.
- Macrophages are crucial targets for HIV-1 infection in vivo.
Purpose of the Study:
- To investigate the interaction between HHV-7 and a macrophage-tropic HIV-1 isolate (HIV-1BaL) in human peripheral blood monocyte-derived macrophages.
- To determine if HHV-7 can inhibit HIV-1 replication in macrophages.
Main Methods:
- Macrophages were exposed to live or UV-inactivated HHV-7 before infection with HIV-1BaL.
- HIV-1 replication was assessed by measuring HIV-1 p24 antigen levels and proviral DNA synthesis.
- The effect of HHV-7 on cell proliferation was evaluated by mitogen stimulation of peripheral blood mononuclear cells (PBMCs).
Main Results:
- Pre-exposure to HHV-7 resulted in a significant dose-dependent inhibition of HIV-1 replication in macrophages (91.7-91.8% reduction in p24 antigen at day 7).
- HHV-7 completely inhibited the synthesis of HIV-1 proviral DNA in the early stages of infection.
- HHV-7 did not inhibit pre-established HIV-1 infections and only marginally affected PBMC proliferation.
Conclusions:
- HHV-7 acts as a potent inhibitor of HIV-1 infection in macrophages, a key cell type for HIV-1 persistence.
- The inhibitory mechanism appears to involve blocking HIV-1 entry, potentially at the CD4 receptor level.
- HHV-7 demonstrates potential as a tool for understanding and potentially combating HIV-1 infection in mononuclear phagocytes.